Ensign Peak Advisors
DXCM icon

Ensign Peak Advisors’s DexCom DXCM Stock Holding History

Ensign Peak Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.49M Sell
140,932
-221,780
-61% -$14.8M 0.02% 447
2026
Q1 		$22.8M Sell
362,712
-336,435
-48% -$23.4M 0.04% 287
2025
Q4 		$46.4M Sell
699,147
-103,188
-13% -$6.67M 0.08% 194
2025
Q3 		$54M Buy
802,335
+596,107
+289% +$47.2M 0.09% 188
2025
Q2 		$18M Sell
206,228
-38,534
-16% -$3.02M 0.03% 336
2025
Q1 		$16.7M Sell
244,762
-29,738
-11% -$2.43M 0.03% 337
2024
Q4 		$21.3M Sell
274,500
-3,813
-1% -$282K 0.04% 309
2024
Q3 		$18.7M Sell
278,313
-32,433
-10% -$2.66M 0.03% 341
2024
Q2 		$35.2M Sell
310,746
-27,067
-8% -$3.42M 0.06% 214
2024
Q1 		$46.9M Sell
337,813
-702,387
-68% -$88.3M 0.09% 199
2023
Q4 		$129M Buy
1,040,200
+361,530
+53% +$36.9M 0.26% 87
2023
Q3 		$63.3M Buy
678,670
+424,979
+168% +$47.9M 0.14% 141
2023
Q2 		$32.6M Buy
253,691
+66,001
+35% +$7.98M 0.07% 224
2023
Q1 		$21.8M Buy
187,690
+3,427
+2% +$384K 0.05% 273
2022
Q4 		$20.9M Buy
184,263
+83,884
+84% +$9.21M 0.05% 288
2022
Q3 		$8.09M Sell
100,379
-49,135
-33% -$4.16M 0.02% 410
2022
Q2 		$11.1M Sell
149,514
-4,946
-3% -$451K 0.03% 365
2022
Q1 		$19.8M Sell
154,460
-127,872
-45% -$14M 0.04% 300
2021
Q4 		$37.9M Buy
282,332
+7,484
+3% +$1.08M 0.07% 226
2021
Q3 		$37.6M Buy
274,848
+19,876
+8% +$2.51M 0.08% 208
2021
Q2 		$27.2M Buy
254,972
+2,884
+1% +$277K 0.05% 269
2021
Q1 		$22.6M Buy
252,088
+29,036
+13% +$2.73M 0.05% 292
2020
Q4 		$20.6M Buy
223,052
+144,960
+186% +$12.9M 0.05% 310
2020
Q3 		$8.05M Buy
78,092
+19,964
+34% +$2.09M 0.02% 487
2020
Q2 		$5.89M Buy
58,128
+55,496
+2,109% +$4.96M 0.02% 567
2020
Q1 		$177K Sell
2,632
-14,368
-85% -$894K ﹤0.01% 1541
2019
Q4 		$930K Buy
+17,000
New +$806K ﹤0.01% 1359

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Ensign Peak Advisors's DXCM Position: Q2 2026 in Review

Ensign Peak Advisors reduced its DexCom (DXCM) stake by 61% in Q2 2026, selling an estimated $14.8M and leaving 140,932 shares worth $9.49M. The position accounts for 0.02% of the portfolio, ranked #447.

Ensign Peak Advisors first reported a position in DXCM in Q4 2019 and has held it in 27 quarters since. The position peaked at $129M in Q4 2023. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Ensign Peak Advisors held 140,932 shares of DexCom worth $9.49M as of Q2 2026.
  • Ensign Peak Advisors sold 221,780 DexCom shares in Q2 2026, an estimated $14.8M.
  • DexCom made up 0.02% of Ensign Peak Advisors's portfolio in Q2 2026, its #447 holding.
  • Ensign Peak Advisors first reported a position in DexCom in Q4 2019 and has held it in 27 quarters since.
  • Ensign Peak Advisors's DexCom position peaked at $129M in Q4 2023.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.